{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:45:15Z","timestamp":1787579115414,"version":"build-2736575974"},"reference-count":18,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Helicobacter pylori ( H. pylori) plays an important role in chronic gastritis and globally it is estimated to be present in half of the world\u2019s population. In Portugal, prevalence reaches 85% and its eradication is recommended using quadruple antibiotic therapy, with or without bismuth. We intended to characterize the prescribed treatments evaluating effectiveness, adverse outcomes and compliance in a real-world setting in a primary care unit. A prospective multicenter observational cohort study was developed in five primary care units of Braga, Portugal. Patients diagnosed with H. pylori infection from August 2021 to January 2022 were included. Data were collected by interview (3 weeks after treatment) and review of medical records. Comparison between two groups of treatment and multivariable analysis was conducted. We estimated 13.4 cases per 1000 adults\/year from 185 diagnoses. Therapy with bismuth was the most prescribed (83.8%) with a 96.7% eradication rate. There were no significant differences between treatments. Adverse events were reported in 73.8% of inquiries and female patients were associated with higher reports of nausea (p = 0.03) and metallic taste (p = 0.02). Both eradication schemes were effective and secure. The higher rate of adverse outcomes should be validated but it could influence the debate concerning treating all patients, especially in low gastric cancer-prevalence regions.<\/jats:p>","DOI":"10.3390\/ijerph191912847","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T22:19:27Z","timestamp":1665267567000},"page":"12847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multicentric Study to Assess Helicobacter pylori Incidence, Patient Reported Adverse Events, Compliance and Effectiveness, in Real-World Setting"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-018X","authenticated-orcid":false,"given":"Andr\u00e9","family":"Mesquita","sequence":"first","affiliation":[{"name":"USF Sanus Carand\u00e1, ACeS C\u00e1vado I-Braga, 4715-402 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-5853","authenticated-orcid":false,"given":"Carlos","family":"Rocha-Castro","sequence":"additional","affiliation":[{"name":"USF do Minho, ACeS C\u00e1vado I-Braga, 4715-402 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-1873","authenticated-orcid":false,"given":"Daniela","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"USF Dr. Pelaez Carones, ACeS C\u00e1vado I-Braga, 4715-402 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8063-0149","authenticated-orcid":false,"given":"Joana","family":"Costa","sequence":"additional","affiliation":[{"name":"USF Gualtar, ACeS C\u00e1vado I-Braga, 4710-078 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-4280","authenticated-orcid":false,"given":"Joana","family":"Soutinho","sequence":"additional","affiliation":[{"name":"USF MaxiSa\u00fade, ACeS C\u00e1vado I-Braga, 4700-036 Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Taveira-Gomes","sequence":"additional","affiliation":[{"name":"MTG Research and Development Lab, 4200-604 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Decision in Health, Faculty of Medicine, University of Porto, 4050-313 Porto, Portugal"},{"name":"Center for Health Technology and Services Research (CINTESIS), 4200-450 Porto, Portugal"},{"name":"Faculty of Health Sciences, University Fernando Pessoa (FCS-UFP), 4249-004 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG Clinical Guideline: Treatment of Helicobacter pylori Infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2019_357","article-title":"Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection","volume":"1149","author":"Kotilea","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e12493","DOI":"10.1111\/hel.12493","article-title":"Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis","volume":"23","author":"Lopo","year":"2018","journal-title":"Helicobacter"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/hel.12061","article-title":"Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults","volume":"18","author":"Bastos","year":"2013","journal-title":"Helicobacter"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: The Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014The Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","article-title":"Helicobacter pylori Infection","volume":"380","author":"Crowe","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","article-title":"Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis","volume":"161","author":"Rokkas","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"Luther","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2050640620972615","article-title":"European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice","volume":"9","author":"Nyssen","year":"2021","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_11","unstructured":"(2022, May 23). Infarmed, Prontu\u00e1rio Terap\u00eautico On-Line. Available online: https:\/\/app10.infarmed.pt\/prontuario\/index.php."},{"key":"ref_12","unstructured":"(2022, May 23). Perfil Local de Sa\u00fade 2018, ACeS de Braga, ARS Norte. Available online: https:\/\/www.arsnorte.min-saude.pt\/wp-content\/uploads\/sites\/3\/2019\/12\/PeLS2018_A6_Braga.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"P217","DOI":"10.1016\/j.amjmed.2005.10.003","article-title":"Smoking Increases the Treatment Failure for Helicobacter pylori Eradication","volume":"119","author":"Suzuki","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression Is a Risk Factor for Noncompliance With Medical Treatment, Meta-analysis of the Effects of Anxiety and Depression on Patient Adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"ref_16","unstructured":"(2022, August 23). Relat\u00f3rio P\u00fablico de Avalia\u00e7\u00e3o Pylera (Subcitrato de Bismuto Pot\u00e1ssico + Metronidazol + Tetraciclina), INFARMED. July 2022. Available online: File:\/\/\/C:\/Users\/Utilizador\/Downloads\/Relatorio_publico_avaliacao_Pylera.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.3748\/wjg.v22.i23.5445","article-title":"Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials","volume":"22","author":"Lin","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"667584","DOI":"10.3389\/fphar.2021.667584","article-title":"Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study","volume":"12","author":"Gravina","year":"2021","journal-title":"Front Pharmacol."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/19\/12847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:47:49Z","timestamp":1760143669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/19\/12847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":18,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijerph191912847"],"URL":"https:\/\/doi.org\/10.3390\/ijerph191912847","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}